ISSN: 1083-4389

Journal Home

Journal Guideline

Helicobacter Q1 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Helicobacter is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 90. It has a price of 2500 €. It has an SJR impact factor of 1,035 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,035.

Helicobacter focuses its scope in these topics and keywords: pylori, helicobacter, infection, h, peptic, ulcer, disease, gastric, systematic, therapy, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Gastroenterology (Q1) Infectious Diseases (Q1) Medicine (miscellaneous) (Q1)

Price

2500 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,035

SJR Impact factor

90

H Index

88

Total Docs (Last Year)

242

Total Docs (3 years)

4829

Total Refs

1108

Total Cites (3 years)

229

Citable Docs (3 years)

4.18

Cites/Doc (2 years)

54.88

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Oxidative Stress in Gastric Mucosa of Asymptomatic Humans Infected with Helicobacter pylori: Effect of Bacterial Eradication

Long-Standing Gastric Mucosal Barrier Dysfunction in Helicobacter pylori-Induced Gastritis in Mongolian Gerbils

Serologic Prevalence of Antibodies to Helicobacter pylori in Internationally Adopted Children

Interleukin-2 Gene Polymorphisms Associated with Increased Risk of Gastric Atrophy from Helicobacter pylori Infection

Helicobacter pylori-Associated Chronic Gastritis and Unexplained Iron Deficiency Anemia: a Reliable Association?

Comparison of Seven and Fourteen Days of Lansoprazole, Clarithromycin, and Amoxicillin Therapy for Eradication of Helicobacter pylori: A Report from India

Inducible Nitric Oxide Synthase Expression in Gastroduodenal Diseases Infected with Helicobacter pylori

Efficacy of Lansoprazole in Eradicating

A Genetic Basis for Atrophy: Dominant Nonresponsiveness and Helicobacter- Induced Gastritis in F1 Hybrid Mice

Changing Patterns of

Effectiveness of Omeprazole-Amoxicillin-Clarithromycin (OAC) Therapy for

Epidemiology of Helicobacter pylori Infection

SHOW MORE ARTICLES

The Incidence of Helicobacter pylori Acquisition in Children of a Canadian First Nations Community and the Potential for Parent-to-Child Transmission

How Do Practicing Clinicians Manage

Increased Primary Resistance to Recommended Antibiotics Negatively Affects Helicobacter pylori Eradication

Predominance of a Single Strain ofHelicobacter pyloriin Gastric Antrum

A Modified McMullen's Staining for

A Protocol for Isolating Putative Helicobacter pylori from Fecal Specimens and Genotyping using vacA Alleles

The Immunobiology of

Pharmacoeconomics of Gastrointestinal Drug Utilisation Prior and Post Helicobacter pylori Eradication

Surface localized Heat Shock Protein 20 (HslV) of Helicobacter pylori

High Dose Omeprazole Plus Amoxicillin and Azithromycin in Eradication of

BOOK REVIEW

Proteome Analysis of Highly Immunoreactive Proteins of Helicobacter pylori